BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38563792)

  • 1. Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
    Jarrot PA; Mirouse A; Ottaviani S; Cadiou S; Salmon JH; Liozon E; Parreau S; Michaud M; Terrier B; Gavand PE; Trefond L; Lavoiepierre V; Keraen J; Rekassa D; Bouldoires B; Weitten T; Roche D; Poulet A; Charpin C; Grobost V; Hermet M; Pallure M; Wackenheim C; Karkowski L; Grumet P; Rogier T; Belkefi N; Pestre V; Broquet E; Leurs A; Gautier S; Gras V; Gilet P; Holubar J; Sivova N; Schleinitz N; Durand JM; Castel B; Petrier A; Arcani R; Gramont B; Guilpain P; Lepidi H; Weiller PJ; Micallef J; Saadoun D; Kaplanski G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2334084. PubMed ID: 38563792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
    J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
    Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster.
    van Sleen Y; van der Geest KSM; Buisman AM; Sandovici M; van Baarle D; Brouwer E
    Arthritis Care Res (Hoboken); 2024 Jan; 76(1):105-110. PubMed ID: 37332051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
    Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
    BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study.
    Manzo C; Castagna A
    Rheumatology (Oxford); 2022 Apr; 61(4):e101-e102. PubMed ID: 34878092
    [No Abstract]   [Full Text] [Related]  

  • 9. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
    Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
    Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
    Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
    Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
    Crowson CS; Matteson EL
    Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
    Singh JA; Cleveland JD
    Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Pipitone N; Versari A; Hunder GG
    Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are polymyalgia rheumatica and giant cell arteritis the same disease?
    Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
    Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.
    Manzo C; Maslinska M; Castagna A; Hysa E; Merante A; Milchert M; Gravina T; Sargin B; Natale M; Ruberto C; Ruotolo G
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917502
    [No Abstract]   [Full Text] [Related]  

  • 16. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
    Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.